Jump to main content or area navigation.

Contact Us

Environmental Assessment

Health Assessment Document for Beryllium. Review Draft

Archive disclaimer
Archived files are provided for reference purposes only. The file was current when produced, but is no longer maintained and may now be outdated. Persons with disabilities having difficulty accessing archived files may contact the NCEA Webmaster for assistance. Please visit http://epa.gov/ncea to access current information.

Report Information

The properties of beryllium resemble those of aluminum, zinc, and magnesium. The main routes of beryllium intake are inhalation and ingestion. The chemical properties of beryllium are such that transformation of soluble to insoluble forms of inhaled beryllium results in long retention time in the lungs. Absorbed beryllium is deposited mainly in the skeleton, where the biological half-time is fairly long. The lung is the critical organ of both acute and chronic noncarcinogenic effects. However, the lung effects caused by chronic exposure may be combined with systemic effects. Certain beryllium compounds have been shown to be carcinogenic in various experimental animals under differing routes of exposure. Epidemiologic studies present equivocal conclusions on the carcinogenicity of beryllium and beryllium compounds. A lifetime cancer risk for continuous inhalation exposure at 1 micrograms beryllium/cu m has been estimated.

Jump to Table of Contents document
U.S. Environmental Protection Agency
Office of Reserach and Development
National Center for Environmental Assessment
Technical Information Staff
  • by phone at:   703-347-8561
  • by fax at:   703-347-8691
  • by email at:  nceadc.comment@epa.gov


Elias, R., K. Lavappa, M. Piscator, A. Reeves, AND C. Sakai. Health Assessment Document for Beryllium. Review Draft. U.S. Environmental Protection Agency, Washington, D.C., EPA/600/8-84/026A (NTIS PB85168433).


Jump to main content.